Search Results

You are looking at 101 - 110 of 277 items for :

  • insulin resistance x
Clear All
Open access

Sandrine Visentin, Gérard Michel, Claire Oudin, Béatrice Cousin, Bénédicte Gaborit, Inès Abdesselam, Marie Maraninchi, Marion Nowicki, René Valéro, Maxime Guye, Monique Bernard, Pascal Auquier, Hervé Chambost, Marie-Christine Alessi and Sophie Béliard

with significantly more pronounced insulin resistance parameters (higher triglycerides, higher plasma glucose levels and lower HDL-C levels) despite lower BMIs and lower waist circumferences when compared to controls ( 15 ). MS is the clinico

Open access

C L Bodinham, L Smith, E L Thomas, J D Bell, J R Swann, A Costabile, D Russell-Jones, A M Umpleby and M D Robertson

. This was highlighted in a scientific advisory committee (SACN) statement on nutrition that stated, although cereal fiber intake has been associated with a reduced incidence of type 2 diabetes (T2DM) and metabolic risk factors such as insulin resistance

Open access

Maria Lola Evia-Viscarra, Edel Rafael Rodea-Montero, Evelia Apolinar-Jiménez and Silvia Quintana-Vargas

accelerate the development of early atherosclerosis beginning in childhood (10) . In both children and adults with obesity and MS, insulin resistance (IR) and chronic inflammation appear to be responsible for the changes that induce complications or

Open access

Ermina Bach, Niels Møller, Jens Otto L Jørgensen, Mads Buhl and Holger Jon Møller

in sCD163 are seen in conditions of low-grade inflammation, such as obesity, insulin resistance and type 2 diabetes mellitus (T2D) ( 17 , 18 , 19 , 20 ), but it is not known if these changes are directly linked to low-grade endotoxinemia or they

Open access

Wang Chengji and Fan Xianjin

Introduction Smoking ( 1 ), low physical activity ( 2 ), obesity, insulin resistance and hyperglycemia ( 3 ) are independently associated with incident type 2 diabetes mellitus (T2DM). Insulin resistance is affected by metabolic risk factors

Open access

Vittorio Unfer, Fabio Facchinetti, Beatrice Orrù, Barbara Giordani and John Nestler

) 17035995 10.1038/nature05185 3 Paul C Laganà AS Maniglio P Triolo O Brady DM. Inositol’s and other nutraceuticals’ synergistic actions counteract insulin resistance in polycystic ovarian syndrome and metabolic syndrome: state

Open access

Janaína Felix Braga, Daniela Ravizzoni Dartora, Natalia Alenina, Michael Bader and Robson Augusto Souza Santos

. Diabetes mellitus is characterized by insulin insufficiency due to either decreased insulin release or end organ insulin resistance. Among the major existing categories of diabetes, type I (T1DM) usually occurs in children and young adults and is

Open access

Kim K B Clemmensen, Jonas S Quist, Dorte Vistisen, Daniel R Witte, Anna Jonsson, Oluf Pedersen, Torben Hansen, Jens J Holst, Torsten Lauritzen, Marit E Jørgensen, Signe Torekov and Kristine Færch

.9% among in-patients, suggesting that the effect of weekend behavior is likely to be attenuated when hospitalized ( 14 ). In a study of 807 Danish children with up to three different visit days, a marker of insulin resistance in the fasting state was found

Open access

Hugo R Ramos, Andreas L Birkenfeld and Adolfo J de Bold

bodyweight as well as with insulin resistance and T2D (19, 74, 75, 76, 77, 78) ( Table 1 ). This correlation can also be observed in patients with congestive heart failure, despite increased cNP levels, due to cardiac wall stress (79) . Several

Open access

Helga Schultz, Svend Aage Engelholm, Eva Harder, Ulrik Pedersen-Bjergaard and Peter Lommer Kristensen

(MSCC) and brain tumours. Diabetes mellitus (DM) is a well-known metabolic side effect from treatment with glucocorticoids. The diabetogenic effect is mainly a result of insulin resistance in muscle and fatty tissue, increased production of glucose from